好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Evaluating Perihematomal Edema Changes and Short-term Functional Recovery After Minimally Invasive Surgery for Intracerebral Hemorrhage
Cerebrovascular Disease and Interventional Neurology
P3 - Poster Session 3 (11:45 AM-12:45 PM)
13-012
To understand the trajectory of early perihematomal edema(PHE) and understand its role in recovery after MIS for ICH evacuation.
PHE plays a significant role in recovery after spontaneous intracerebral hemorrhage (ICH).  Its formation is multifactorial, including shifts in hydrostatic pressure, osmotic gradients, tissue ischemia, hemolysis, and cytotoxic edema due to neuronal injury. However, its trajectory and relationship with short-term outcomes following minimally invasive surgery (MIS) for ICH evacuation remain poorly understood.

We analyzed 16 consecutive patients presenting with ICH who underwent MIS hematoma evacuation. A prospective registry was created for data collection. Edema extension distance, hematoma and perihematoma volumes were calculated by two independent investigators using the validated volumetric measurement method of ABCD/2, and multivariable linear regression identified key associations. 


Our results show that PHE increased progressively from deep, to cortical, to both deep and cortical bleed locations after controlling for confounders (p=0.047). Additionally, a deeper hemorrhage location (p=0.003),  lower admission GCS (p=0.039) and paradoxically, a postoperative decrease in PHE (p=0.037) were associated with worse discharge outcomes, suggesting early PHE might reflect a protective or reparative response. 


In our small cohort, a decrease in PHE immediately after MIS evacuation was associated with worse mRS scores at discharge. These findings challenge the assumption that reducing PHE is uniformly beneficial. Instead, early PHE may signal neuroprotection or active healing, underscoring the need to reconsider therapeutic strategies. Larger studies are warranted to clarify the complex role of PHE in ICH recovery and inform targeted interventions.


Authors/Disclosures
Emma Frost, MD
PRESENTER
Dr. Frost has nothing to disclose.
Anika Pruthi Ms. Pruthi has nothing to disclose.
Daniel Tonetti, MD Dr. Tonetti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Route 92 Medical. Dr. Tonetti has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IRRAS.
Fred Rincon, MD (Thomas Jefferson University) Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for NeuroCrit, LLC. Dr. Rincon has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for NeuroCrit LLC.
Khalid Hanafy, MD, PhD (Beth Israel Deaconess Medical Ctr) Dr. Hanafy has nothing to disclose.
Swarna Rajagopalan, MD (Cooper University Healthcare) Dr. Rajagopalan has nothing to disclose.